CTOs on the Move

BioRx

www.biorx.com

 
Founded in 2004, BioRx is a national provider of specialty pharmacy, infusion management and industry consulting services. As a private, independently-owned company, BioRx is committed to a flexible service model that meets the needs of its customers, including consumers, healthcare providers, health plans and pharmaceutical manufacturers. The company’s streamlined management structure allows it to respond more quickly to changes in the marketplace and provide a higher level of service that is customized for each consumer. Moreover, BioRx helps to provide a more cost-effective level of healthcare – in particular by moving patients from costly facility-based infusion sites to their homes, thereby ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.biorx.com
  • 10828 Kenwood Rd
    Cincinnati, OH USA 45242
  • Phone: 866.442.4679

Executives

Name Title Contact Details

Similar Companies

InfuSystem Holdings

Geonetric

Geonetric is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellness Resource Group

Wellness Resource Group is a Bayport, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meadowbrook Medical Care

Meadowbrook Medical Care is a Bellaire, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.